Molecular characterization and distribution of the opioid growth factor receptor (OGFr) in mouse.
Journal
  Brain research. Molecular brain research.
Citation
  Brain Res Mol Brain Res. 84(1-2):106-14
Publication date
  2000 Dec 8
Authors
  Zagon IS
Verderame MF
Zimmer WE
McLaughlin PJ
Investigators
  Patricia J. McLaughlin
Michael F. Verderame
Ian S. Zagon
Grant agencies
  National Cancer Institute
National Eye Institute
Grants
  NCI CA66783
NEI EY10300
MeSH headings
  Receptors, Opioid
MeSH qualifiers
  analysis
chemistry
Abstract
  The native opioid growth factor (OGF), [Met(5)]-enkephalin, is a tonic inhibitory peptide that modulates cell proliferation and tissue organization during development, cancer, cellular renewal, wound healing, and angiogenesis. OGF action is mediated by a receptor mechanism. The receptor for OGF, OGFr, has been cloned and sequenced in humans and rats. Using primers based on the rat OGFr cDNA, and a mouse embryo expressed sequence tag, the full-length 2.1 kb mouse OGFr cDNA was sequenced. The open reading frame was found to encode a protein of 634 amino acids, and 14 imperfect repeats of 9 amino acids each were a prominent feature. The molecular weight of OGFr was calculated as 70679, and the isoelectric point was 4.5. Northern blot analysis revealed a 2.1 kb OGFr mRNA transcript in adult mouse brain, heart, lung, liver, kidney, and triceps surae muscle. The amino acids for mouse and rat OGFr were 93% similar and 91% identical, but the mouse and human shared only a 70% similarity and a 58% identity. These results emphasize the molecular validity of OGFr, and explain the interaction of OGF with respect to normal and abnormal growth in mouse cells and tissues.
Medline ID
  20565727